Inventor · disambiguated record
Zhenxing Du
Also filed as: DU ZHENXING
6 granted patents·16 pending applications·1 citations·filing 2014–2024
65Inventor score
Files withJIANGSU HENGRUI MEDICINE CO10JIANGSU HENGRUI PHARMACEUTICALS CO LTD10NOVARTIS AG1SMOORE INTERNATIONAL HOLDINGS LTD1
Top patents by PatentIndex Score
22 records- 0166US2025072471A1Method for preparing additive liquid of atomizer, additive liquid, and atomizerSMOORE INTERNATIONAL HOLDINGS LTD·Filed 2024·Application pending·0 cites
- 0264US9840498B2Substituted quinazolin-4-one derivativesNOVARTIS AG·Filed 2014·Granted Dec 12, 2017·1 cites·15 claims
- 0360US2025382287A1Pharmaceutically acceptable salt and crystal form of nitrogen-containing bridge heterocyclic derivative, and method for preparing sameJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 0457US2025326743A1Crystal forms of triazine dione derivative and preparation method thereforJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 0557US2025320194A1Pharmaceutically acceptable salt and crystal form of fused pyridine ring derivative and preparation method thereforJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0654US2025145641A1Fused bicyclic derivative, pharmaceutically acceptable salt, crystal form thereof and preparation method thereforJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0754US2025154126A1Crystalline form of sulfur-containing isoindoline derivativeJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 0854US2025049777A1Pharmaceutically acceptable salt and crystalline form of glp-1 receptor agonist and preparation method thereforJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 0951US2022411380A1ACID ADDITION SALT OF RORy REGULATORJIANGSU HENGRUI MEDICINE CO·Filed 2020·Application pending·0 cites
- 1050US2025049778A1Crystalline form of glp-1 receptor agonist and preparation method thereforJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1150US2024374581A1Salt types of tricyclic tetrahydro isoquinoline derivativeJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1249US2022233449A1Solid dispersion and preparation method thereforJIANGSU HENGRUI MEDICINE CO·Filed 2020·Application pending·0 cites
- 1348US12269823B2Crystal form of pyridopyrimidine derivative and preparation method thereofJIANGSU HENGRUI MEDICINE CO·Filed 2020·Granted Apr 8, 2025·0 cites·17 claims
- 1447US2023331731A1Crystal form of pyrrolo heterocyclic derivative and preparation method thereforJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1546US11155537B2Crystal of benzofuran derivative free base and preparation methodJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Oct 26, 2021·0 cites·17 claims
- 1646US2024262823A1Pharmaceutically acceptable salt of pyrazoloheteroaryl derivative and crystal form thereofJIANGSU HENGRUI PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1745US11299462B2Crystal form of oxopicolinamide derivative and preparation method thereforJIANGSU HENGRUI MEDICINE CO·Filed 2019·Granted Apr 12, 2022·0 cites·19 claims
- 1844US2022081446A1Crystal form of 1,2,3-triazolo[1,5-a]pyrazines derivative and preparation method for crystal formJIANGSU HENGRUI MEDICINE CO·Filed 2020·Application pending·0 cites
- 1943US11225462B2Crystal forms of oxypyridine amide derivative and preparation method thereforJIANGSU HENGRUI MEDICINE CO·Filed 2019·Granted Jan 18, 2022·0 cites·14 claims
- 2043US11014888B2Crystalline form of alkynyl pyridine prolyl hydroxylase inhibitor and method for preparing sameJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted May 25, 2021·0 cites·17 claims
- 2143US2021188856A1Crystal form of hydrochloride of pyrazoloheteroaryl derivative and preparation methodJIANGSU HENGRUI MEDICINE CO·Filed 2019·Application pending·0 cites
- 2241US2021355109A1Crystal form of maleate of tyrosine kinase inhibitor and preparation method thereforJIANGSU HENGRUI MEDICINE CO·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhenxing Du files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →